Integrins โฃ2โค1, โฃ3โค1, and โฃ6โค4 are expressed in the epidermis, and play an important role in wound healing and/or epidermal-dermal interaction. These integrins may provide a new perspective into the understanding of wound healing and vesication. The isolated perfused porcine skin flap (IPPSF) has be
Topography and biological role of integrins in human skin
โ Scribed by Marchisio, Pier Carlo; Trusolino, Livio; De Luca, Michele
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 248 KB
- Volume
- 38
- Category
- Article
- ISSN
- 1059-910X
No coin nor oath required. For personal study only.
โฆ Synopsis
We report the topography of integrins in the human epidermis and in cultured human keratinocytes. Both in situ and in vitro โค1 integrins are exposed at the cell-cell adhesion interface while โค4 is located on the basal membrane in contact with the basal lamina. Such defined sorting identifies discrete cell membrane domains that may be involved in defining, building up, and maintaining epithelial cell polarity. The distribution of integrins is deeply altered in hyperproliferative states like those occurring in several experimental conditions and in epidermal diseases.
๐ SIMILAR VOLUMES
The Ca 2ฯฉ -dependent cell-cell adhesion molecules, termed cadherins, are subdivided into several subclasses. E (epithelial)-and P (placental)-cadherins are involved in the selective adhesion of epidermal cells. E-cadherin is expressed on the cell surfaces of all epidermal layers and P-cadherin is e
The factors that determine the metastatic behavior of pancreatic tumor cells are incompletely understood. In this study, we first demonstrate differences in adhesion properties, integrin expression and in vivo integrin function in the metastatic tumor cell line PaTu 8988s compared with the non-metas
Noninvasive techniques that provide detailed information about molecular composition, structure, and interactions are crucial to further our understanding of the relation between skin disease and biochemical changes in the skin, as well as for the development of penetration enhancers for transdermal
A comparative pharmacokinetic trial was performed with a superpotent synthetic melanotropic peptide, [Nle4-D-Phe7]-alpha-MSHi-13 (melanotan-I or MT-I) given by three routes of administration. Plasma levels were measured by RIA and tanning was quantiated using serial reflectometry. Doses of 0.16 mgkg